This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase II, Open-Label Study To Assess The Efficac...
Clinical trial

A Phase II, Open-Label Study To Assess The Efficacy and Tolerability of ZD6474 (ZACTIMA� ) 100 mg Monotherapy In Subjects with Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer

Read time: 1 mins
Last updated:20th Apr 2006
To determine the objective response rate in subjects treated with ZD6474 (ZACTIMA� ) 100 mg monotherapy
Category Value
Study start date 2006-04-20

View full details